Document is current
Any future updates will be listed below
-
Authors
Fonda, Federico
Faruzzo, Alda
Bellini, Gabriella
Provenzano, Antonio
Lampis, Emanuele
Brunelli, Laura
Marzinotto, Stefania
Pipan, Corrado
Curcio, Francesco
Privitera, Gaetano
Palese, Alvisa
Arnoldo, Luca
Brusaferro, Silvio
-
Funding
Funding for this research was provided by:
Elettronica SpA (/)
- License Information
-
More Information
Article History
Received: 12 June 2026
Accepted: 4 August 2026
First Online: 21 August 2026
Declarations
Ethics approval and consent to participate: Written informed consent was obtained from all participants. The study was approved by the Ethical Committee of the Friuli Venezia Giulia Region (CEUR), with approval number CEUR-2025-Sper-04 and successive amendments. The study was conducted in accordance with the ethical principles of the Declaration of Helsinki and with the relevant national guidelines and regulations.
Consent for publication: Not applicable.
Competing interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. L.B. and S.B. received personal grants from Pfizer, S.B. received personal grants from Shionogi, all outside this work. S.B. and G.P. are members of the advisory board of e4life srl.
